Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin.

Gudjonsson JE, Ding J, Li X, Nair RP, Tejasvi T, Qin ZS, Ghosh D, Aphale A, Gumucio DL, Voorhees JJ, Abecasis GR, Elder JT.

J Invest Dermatol. 2009 Dec;129(12):2795-804. doi: 10.1038/jid.2009.173. Epub 2009 Jul 2.

2.

MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R.

Lerman G, Avivi C, Mardoukh C, Barzilai A, Tessone A, Gradus B, Pavlotsky F, Barshack I, Polak-Charcon S, Orenstein A, Hornstein E, Sidi Y, Avni D.

PLoS One. 2011;6(6):e20916. doi: 10.1371/journal.pone.0020916. Epub 2011 Jun 7.

3.

Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.

Johansen C, Flindt E, Kragballe K, Henningsen J, Westergaard M, Kristiansen K, Iversen L.

J Invest Dermatol. 2005 Jun;124(6):1284-92.

4.

Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models.

Gudjonsson JE, Ding J, Johnston A, Tejasvi T, Guzman AM, Nair RP, Voorhees JJ, Abecasis GR, Elder JT.

J Invest Dermatol. 2010 Jul;130(7):1829-40. doi: 10.1038/jid.2010.36. Epub 2010 Mar 11.

5.

Evidence for altered Wnt signaling in psoriatic skin.

Gudjonsson JE, Johnston A, Stoll SW, Riblett MB, Xing X, Kochkodan JJ, Ding J, Nair RP, Aphale A, Voorhees JJ, Elder JT.

J Invest Dermatol. 2010 Jul;130(7):1849-59. doi: 10.1038/jid.2010.67. Epub 2010 Apr 8.

6.

Lack of evidence for activation of the hedgehog pathway in psoriasis.

Gudjonsson JE, Aphale A, Grachtchouk M, Ding J, Nair RP, Wang T, Voorhees JJ, Dlugosz AA, Elder JT.

J Invest Dermatol. 2009 Mar;129(3):635-40. doi: 10.1038/jid.2008.266. Epub 2008 Aug 28.

7.

Identification of differentially expressed genes in psoriasis using expression profiling approaches.

Itoh K, Kawasaki S, Kawamoto S, Seishima M, Chiba H, Michibata H, Wakimoto K, Imai Y, Minesaki Y, Otsuji M, Okubo K.

Exp Dermatol. 2005 Sep;14(9):667-74.

PMID:
16098126
8.

Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN.

Keermann M, Kõks S, Reimann E, Prans E, Abram K, Kingo K.

BMC Genomics. 2015 Apr 19;16:322. doi: 10.1186/s12864-015-1508-2.

9.

hMena: altered expression in psoriatic skin.

Cardinali G, Kovacs D, Mastrofrancesco A, Cota C, Donati P, Cordiali-Fei P, Francesconi F, Bonifati C.

Arch Dermatol Res. 2013 Dec;305(10):933-8. doi: 10.1007/s00403-013-1358-1. Epub 2013 Apr 21.

PMID:
23604962
10.

A subset of methylated CpG sites differentiate psoriatic from normal skin.

Roberson ED, Liu Y, Ryan C, Joyce CE, Duan S, Cao L, Martin A, Liao W, Menter A, Bowcock AM.

J Invest Dermatol. 2012 Mar;132(3 Pt 1):583-92. doi: 10.1038/jid.2011.348. Epub 2011 Nov 10.

11.

Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin.

Tsoi LC, Iyer MK, Stuart PE, Swindell WR, Gudjonsson JE, Tejasvi T, Sarkar MK, Li B, Ding J, Voorhees JJ, Kang HM, Nair RP, Chinnaiyan AM, Abecasis GR, Elder JT.

Genome Biol. 2015 Jan 30;16:24. doi: 10.1186/s13059-014-0570-4.

12.

Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.

Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY.

J Immunol. 2003 Sep 15;171(6):3262-9.

13.

The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes.

Tiala I, Suomela S, Huuhtanen J, Wakkinen J, Hölttä-Vuori M, Kainu K, Ranta S, Turpeinen U, Hämäläinen E, Jiao H, Karvonen SL, Ikonen E, Kere J, Saarialho-Kere U, Elomaa O.

J Mol Med (Berl). 2007 Jun;85(6):589-601. Epub 2007 Jan 13.

PMID:
17221218
14.
15.

Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis.

Mehta NN, Li K, Szapary P, Krueger J, Brodmerkel C.

J Transl Med. 2013 Aug 22;11:194. doi: 10.1186/1479-5876-11-194.

16.

Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity.

Quekenborn-Trinquet V, Fogel P, Aldana-Jammayrac O, Ancian P, Demarchez M, Rossio P, Richards HL, Kirby B, Nguyen C, Voegel JJ, Griffiths CE.

Br J Dermatol. 2005 Mar;152(3):489-504.

PMID:
15787818
17.

Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes.

Oyama N, Takahashi H, Tojo M, Iwatsuki K, Iizuka H, Nakamura K, Homma Y, Kaneko F.

Arch Dermatol Res. 2002 Aug;294(6):273-80. Epub 2002 Jul 20.

PMID:
12192491
18.

Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.

Johansen C, Kragballe K, Rasmussen M, Dam TN, Iversen L.

Br J Dermatol. 2004 Sep;151(3):600-7.

PMID:
15377346
19.

Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).

van der Fits L, van der Wel LI, Laman JD, Prens EP, Verschuren MC.

J Pathol. 2003 Jan;199(1):107-14.

PMID:
12474233
20.

Psoriatic skin expresses the transcription factor Gli1: possible contribution of decreased neurofibromin expression.

Endo H, Momota Y, Oikawa A, Shinkai H.

Br J Dermatol. 2006 Apr;154(4):619-23.

PMID:
16536802
Items per page

Supplemental Content

Write to the Help Desk